Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy

NCT00458887 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00458887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00458887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
May 31, 2007
Completion date
February 28, 2017
Enrollment
301 (actual)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

ototoxicity, unspecified childhood solid tumor, protocol specific